KARAM BIOSCIENCE
Cell-State Panel
Public scope outline / 2026-10-15

Proposed research work, not an accepted engagement or demonstrated result.

DECISION
The proposed Cell-State Panel combines multiple indicators of senescence, viability and function within an agreed research model. The objective is to understand whether the measurements tell a coherent story. Discordant results should be reported, not collapsed into a single rejuvenation score.

READINESS
Laboratory agreement required

PLANNING BUDGET; NOT A QUOTE
$15,000–$40,000 all-in pilot proposed

TIMING CONDITION
Only after a complete written laboratory quote

DELIVERABLES
Model-specific assay scope: Define the comparison, readouts, sample structure and the decision the panel should support.
Viability and interpretation context: Plan how apparent beneficial changes will be distinguished from cell loss or an altered sample composition.
Quality and repeat rules: Laboratory acceptance criteria, controls, failed runs and responsibility for repeating work documented before ordering.
Integrated research report: Present each readout, uncertainty and disagreement without turning marker change into a lifespan claim.

INPUTS
Cell-model information, intended comparison, material availability, candidate readouts and budget. A signed partner scope, capacity and commercial-use rights are prerequisites.

ACCEPTANCE
A complete, quality-controlled dataset and reviewed interpretation against the agreed research question. The all-in range is a planning hypothesis pending vendor quotes, not a published assay rate card.

BOUNDARIES
No physical kit currently offered, no clinical diagnosis, no human age score and no claim of lifespan extension from a marker shift.